Right Turn: Prof. Molly Shoichet shares her views on commercialization

Author: Stacey Johnson, 05/16/14

.

Last November, I wrote about CCRM’s new Regenerative Medicine Video Network and featured an original video with Dr. Stephen Minger, Chief Scientist, Cellular Sciences GE Healthcare Life Sciences in the UK. If you enjoyed his industry perspective and insights on exciting developments and commercialization in the regenerative medicine field, I think you’ll be equally interested in hearing from an academic who covers the same topics, but from a markedly different point of view.

Dr. Molly Shoichet is a professor at the University of Toronto with the Institute of Biomaterials and Biomedical Engineering. She is an advisor and collaborator with CCRM. Dr. Shoichet holds the Tier 1 Canada Research Chair in Tissue Engineering and she is an award-winning researcher. And she’s very excited about current research in the regenerative medicine field.

Our regular feature, Right Turn, showcases the “lighter” side of stem cells and regenerative medicine. Every Friday, we will bring you cartoons, photos, videos and other content that may be just as thought provoking as the written submissions that you are used to finding here, but they definitely won’t be blogs.

As always, we welcome your feedback and we also welcome suitable submissions. Be creative! Use the right (!) side of your brain. Make us laugh! Let’s see if we can make this new direction a positive one for all of us. Send your submission to info(at)ccrm.ca.

The following two tabs change content below.
Stacey Johnson

Stacey Johnson

For almost 20 years, Stacey has been providing strategic communications counsel to government, corporate, technology and health organizations. Prior to that, Stacey was at the CTV Television Network, first as a researcher, then as a story producer for “Goldhawk Fights Back,” a special ombudsman segment that aired weekly on the National News and Canada AM. Before joining CCRM as the Director, Communications and Marketing, Stacey was the Director of Communications for the Canadian Arthritis Network. Stacey is editor of Signals. You can follow Stacey on Twitter @msstaceyerin.
Tags: , , , , , , , , , , , ,

One Response

  1. John Smith says:

    It’s criminal that they haven’t allowed experimental use of these SAFE stem cell treatments for AMD. Politics and money should not be obstructing something that can reduce healthcare costs in this country.

Leave a Reply

*
*